From: treon3verdery@gmail.com   
      
   Another way to make a GABA active drug to block IT pattern recruitment and   
   awareness:   
      
   Attach an antibody to a protein that is gradually, sectionally taken apart by   
   an endogenous enzyme, the antibody could be liposomally surrounded and enteric   
   coated so it is absorbed from an oral dose, snorting it could also be   
   effective. Once dosed the    
   antibody protein gloms tissue that is harmless to glom, plentiful but   
   predictable proteolytic enzymes at the circulatory system, or at some   
   versions, that are produced at the cell environment or tissue, Then the   
   proteolytic enzyme removes, at a protein    
   sequence possibly shaped like a stack of linoleum tiles with a layer of fun   
   sized candy bars, that are actually GABA receptor actibating peptide strings.   
   in between them, at the actual molecules one of the alternating layers is   
   hydrophilic or lipophilic    
   and the other layer is at the drugs natural lipophilicity or hydrophilicity   
   and pH. another possibility is like a particularly affordable to make where   
   drugs, like GABA peptide drugs are made into 40 merish long amino acid   
   strings, attached to and spaced    
   with enzyme degradable linkers like GGG (gly-gly-gly) that release the   
   separated drug-active GABA peptides, likely to the circulatory system although   
   the lymphatic system or cerebrospinal fluids could also be functional, when   
   the circulating or area    
   endogenous enzymes see the    
      
   Gene therapy that makes this drug is also possible as a version of a 1% volume   
   form of one of mamy different serum albumins could be made to have codon   
   sequences that made a whole bunch of GGG-multimer GABA active peptide   
   sequence-GGG at the construction    
   of the larger albumin protein that is exposed to the enzymes at the   
   circulatory system, that causes the person to always be on GABA active   
   peptides, dosing studies to find out how many GGG-GABA peptide activator   
   sequence copies to put at the albumin gene    
   can be done with primates   
      
   If there are 7 albumins and globulins the intention of getting a full function   
   first dose is pteferref but is also technologically extended snd ensured   
   because each of the 7 albumins and globulins can be sequentially gene therapy   
   modified to make the    
   GABA active peptide to titrate the dose upward to optimal amounts.   
      
   drug chemistry, out 1/1100 the of it every 24 hours, whenever the enzyme   
   functions (detaches an available part of the molecule) a fresh dose of drug   
   peptide (like a pattern recruitment reducing drug peptide a longevizing   
   peptide or a different drug    
   peptide) is also portablizedmade a circulating physiochemical at the   
   circulatory system then the person experiences the beneficial decreased   
   pattern recruitment and awareness, as well as drug forms that heighten   
   longevity   
      
   A beneficial drug, like a lifesaving drug, that benefits children, i think   
   some proteins are only msde at children, the genes that make these proteins   
   can be upgraded with new versions that also make protein and peptide drugs   
   that are beneficial to the    
   children   
      
   Out of 100 children, 30 will be at or below the 30th percentile, heightening   
   immunofunction to be like that of 90th percentile of immunoresponse that   
   prevents, cures and vauses revory from unwellness is beneficial.   
      
   Dominant genes modified to make a wider range of immunofunctionalizing   
   chemicals with gene therapy as well as beneficial germline modification   
   modifies dominant genes, only one of which is required to beneficially change   
   the chemical production phenotype    
   to improve immune response. This increases the immune response, that is the   
   immunofunctionality even when there are a phenotype formimg recessive genes of   
   ptevipusly less than optimal immunochemistry stimulation than would combine to   
   make a wellness    
   producing, fully immune functional chemical production.    
      
   So at the distribution of recessive gene function, at recessive and dominant   
   immunofunction genes that are expressed as phenotypic functionality there   
   would be 1/4 effectiveness at II,Ii, Ii, (I is full immunochemical dominant   
   gene production, Ii is    
   partial production and ii is the less functional double recessive genotype   
   that is at 1/4 of the population. When double recessive ii at the general   
   population causes proneness to more illmess, greater severity, or both then   
   moving the production of that    
   chemical to a recessive gene heightens immunofunction so one I or i allele is   
   sufficient to produce all the immunochemicals a II person has.   
      
   Making it so ii double recessives, 1/4 of the population, have II gene   
   function's more effective immunofunction ensures against very many diseases,   
   including any new diseases and reduces illness at the population as the   
   Dominant gene versions of    
   beneficial things that heighten beneficial function at the immune system,   
   replace and complement the various versions or combinations of recessive genes   
   which might accumulate and average out to half (0.0, .5, .5, 1.0)   
      
   Moving the least 30 immunofunctional children at the USA to 90th percentile   
   would decrease annoying illness and make people feel better. Globally it could   
   save many lives as it is possible to imagine that the children that get   
   malaria and diarrhea are    
   frequently at the lesser 30th percentile of immune function. Moving all those   
   children up to 90th percentile could reduce occurrence of illness and any   
   result of illness more than 4/5, imaginably to 4/5 of all lives being saved. i   
   read there is some    
   mathematics associated with that 1/5th of the activity or thing produces 4/5   
   of the measured effect.  It is possible that raising the immune capability of   
   the least immunocapable 1/3  will save 4/5 of the people that ceased being   
   alive from childhood    
   unwellnesses. That is associated with that the 30% of children most likely to   
   become unwell likely represented more than 30% of the historic occurences of   
   not being alive. I think decreasing all childhood infectious disease to 4/5 as   
   much as they    
   previously were and saving 4/5 the lives of all the children who would   
   otherwise not be alive is beneficial and gives gene therapy a beneficial   
   reputation, supporting even more beneficial kinds of gene therapy.    
      
      
   [continued in next message]   
      
   --- SoupGate-Win32 v1.05   
    * Origin: you cannot sedate... all the things you hate (1:229/2)